Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7007

1.

Amyotrophic Lateral Sclerosis: A Focus on Disease Progression.

Calvo AC, Manzano R, Mendonça DM, Muñoz MJ, Zaragoza P, Osta R.

Biomed Res Int. 2014;2014:925101. Epub 2014 Aug 3. Review.

PMID:
25157374
[PubMed - as supplied by publisher]
2.

The characterization of biological rhythms in mild cognitive impairment.

Ortiz-Tudela E, Martinez-Nicolas A, Díaz-Mardomingo C, García-Herranz S, Pereda-Pérez I, Valencia A, Peraita H, Venero C, Madrid JA, Rol MA.

Biomed Res Int. 2014;2014:524971. doi: 10.1155/2014/524971. Epub 2014 Jul 17.

PMID:
25157363
[PubMed - in process]
3.

Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic.

Duits FH, Prins ND, Lemstra AW, Pijnenburg YA, Bouwman FH, Teunissen CE, Scheltens P, van der Flier WM.

Alzheimers Dement. 2014 Aug 21. pii: S1552-5260(14)02461-3. doi: 10.1016/j.jalz.2014.05.1753. [Epub ahead of print]

PMID:
25156643
[PubMed - as supplied by publisher]
4.

Editorial: Overview of Immunotherapy in Alzheimer's Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD.

Counts SE, Lahiri DK.

Curr Alzheimer Res. 2014;11(7):623-5.

PMID:
25156573
[PubMed - in process]
5.

Subjective Cognitive Complaints Contribute to Misdiagnosis of Mild Cognitive Impairment.

Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW.

J Int Neuropsychol Soc. 2014 Aug 26:1-12. [Epub ahead of print]

PMID:
25156329
[PubMed - as supplied by publisher]
6.

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.

Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O.

JAMA Neurol. 2014 Aug 25. doi: 10.1001/jamaneurol.2014.1358. [Epub ahead of print]

PMID:
25155658
[PubMed - as supplied by publisher]
7.

Mapping Dynamic Changes in Ventricular Volume onto Baseline Cortical Surfaces in Normal Aging, MCI, and Alzheimer's Disease.

Madsen SK, Gutman BA, Joshi SH, Toga AW, Jack CR Jr, Weiner MW, Thompson PM.

Med Image Comput Comput Assist Interv. 2013;8159:84-94.

PMID:
25152934
[PubMed]
8.

[Ethical considerations regarding the communication of diagnosis of prodromal Alzheimer's disease].

Serrano CM, Sorokin P, Taragano F.

Vertex. 2014 Mar-Apr;25(114):99-101. Spanish.

PMID:
25153975
[PubMed - in process]
9.

Alzheimer's disease biomarkers detection in human samples by efficient capturing through porous magnetic microspheres and labelling with electrocatalytic gold nanoparticles.

de la Escosura-Muñiz A, Plichta Z, Horák D, Merkoçi A.

Biosens Bioelectron. 2014 Aug 7. pii: S0956-5663(14)00589-2. doi: 10.1016/j.bios.2014.07.086. [Epub ahead of print]

PMID:
25153932
[PubMed - as supplied by publisher]
10.

Current guidelines for dementia screening: shortcomings and recommended changes.

Tolea MI, Galvin JE.

Neurodegener Dis Manag. 2013 Dec;3(6):565-573.

PMID:
25152772
[PubMed]
11.

MicroRNA-135a and -200b, potential Biomarkers for Alzheimer's disease, regulate β secretase and amyloid precursor protein.

Liu CG, Wang JL, Li L, Xue LX, Zhang YQ, Wang PC.

Brain Res. 2014 Aug 21. pii: S0006-8993(14)00543-5. doi: 10.1016/j.brainres.2014.04.026. [Epub ahead of print]

PMID:
25152461
[PubMed - as supplied by publisher]
12.

Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

Cacabelos R, Cacabelos P, Torrellas C, Tellado I, Carril JC.

Methods Mol Biol. 2014;1175:323-556. doi: 10.1007/978-1-4939-0956-8_13.

PMID:
25150875
[PubMed - in process]
13.

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative.

Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L.

Alzheimers Dement. 2014 Aug 20. pii: S1552-5260(14)00109-5. doi: 10.1016/j.jalz.2014.03.003. [Epub ahead of print] Review.

PMID:
25150736
[PubMed - as supplied by publisher]
14.

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey.

Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Olde Rikkert M, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin AK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB.

Alzheimers Dement. 2014 Aug 20. pii: S1552-5260(14)02465-0. doi: 10.1016/j.jalz.2014.06.006. [Epub ahead of print]

PMID:
25150733
[PubMed - as supplied by publisher]
15.

Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Bertens D, Knol DL, Scheltens P, Visser PJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Aug 20. pii: S1552-5260(14)02462-5. doi: 10.1016/j.jalz.2014.05.1754. [Epub ahead of print]

PMID:
25150730
[PubMed - as supplied by publisher]
16.

Biomarkers for neurology: Guides and lines.

Fleming JO, Carlsson CM.

Neurology. 2014 Aug 22. pii: 10.1212/WNL.0000000000000825. [Epub ahead of print] No abstract available.

PMID:
25150288
[PubMed - as supplied by publisher]
17.

Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression.

Diniz BS, Teixeira AL, Machado-Vieira R, Talib LL, Radanovic M, Gattaz WF, Forlenza OV.

J Gerontol B Psychol Sci Soc Sci. 2014 Aug 22. pii: gbu096. [Epub ahead of print]

PMID:
25149921
[PubMed - as supplied by publisher]
18.

CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease.

Hermann P, Romero C, Schmidt C, Reis C, Zerr I.

PLoS One. 2014 Aug 22;9(8):e105000. doi: 10.1371/journal.pone.0105000. eCollection 2014.

PMID:
25147945
[PubMed - in process]
19.

Brain Changes in Alzheimer's Disease Patients with Implanted Encapsulated Cells Releasing Nerve Growth Factor.

Ferreira D, Westman E, Eyjolfsdottir H, Almqvist P, Lind G, Linderoth B, Seiger A, Blennow K, Karami A, Darreh-Shori T, Wiberg M, Simmons A, Wahlund LO, Wahlberg L, Eriksdotter M.

J Alzheimers Dis. 2014 Aug 21. [Epub ahead of print]

PMID:
25147108
[PubMed - as supplied by publisher]
20.

Structural Imaging Measures of Brain Aging.

Lockhart SN, DeCarli C.

Neuropsychol Rev. 2014 Aug 22. [Epub ahead of print]

PMID:
25146995
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk